Matthew Frohn

Matthew is a founding partner at Longwall Ventures based at Harwell.  He has a D.Phil in Biochemistry from the University of Oxford.  His pre-venture experience ranges from working in clinical pathology to virology with Zeneca and drug development with Neures. Matthew began venture investing in 1999 and has worked with several investee companies either as an interim manager or board director.